PerkinElmer Stock Price and Value Analysis

Should you buy PerkinElmer stock? (NYSE:PKI). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
  • This company is very stable.
  • This company has a low dividend yield.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company is not making money.

PKI Free Cash Flow Trend

Hmm, we can't give any reliable projection for PerkinElmer's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for PKI
Free Cash Flow trendline for PerkinElmer

Inside the PKI Numbers

PKI Price
(PerkinElmer stock price per share)
$83.76
[?] PE Ratio versus Sector 34% higher than other Healthcare stocks
[?] PE Ratio versus Industry 86% lower than other Diagnostics & Research stocks
[?] Cash Yield 17.38%
[?] Free Cash Flow Jitter 71%
[?] Dividend Yield 0%

Is PerkinElmer Stock on Sale?

Based on our analysis, we believe that you should not buy PerkinElmer right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy PKI Stock?

Does PerkinElmer have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.